Journal Logo

Simultaneous Sessions II: Lymphoma biology & translational research

S844 KDM5 INHIBITION OFFERS A NOVEL THERAPEUTIC STRATEGY FOR THE TREATMENT OF KMT2D MUTANT LYMPHOMAS

Heward, J.1; Koniali, L.1; D’Avola, A.2; Close, K.1; Yeomans, A.2; Johnson, P.2; Okosun, J.1; Neve, R.3; Gribben, J.1; Oppermann, U.4; Packham, G.2; Fitzgibbon, J.1

Author Information
doi: 10.1097/01.HS9.0000561656.72982.67
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.